Versant Venture Management

Latest statistics and disclosures from Versant Venture Management's latest quarterly 13F-HR filing:

  • Versant Venture Management was a net seller of stock by $0.

Versant Venture Management portfolio companies for December 2016 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Audentes Therapeutics Inc Com stock 32.13 1.81M 18.27 0.00
Ocular Therapeutix 18.05 2.22M 8.37 0.00
Clovis Oncology 17.61 407416 44.42 0.00
Achaogen 16.24 1.28M 13.02 0.00
Immune Design 11.82 2.21M 5.50 0.00
Glaukos 2.38 71428 34.30 0.00
Cymabay Therapeutics 1.77 1.05M 1.73 0.00